The ability of PBC-specific markers to identify patients presenting with severe disease was hence tested by comparing the positivity of nuclear autoantibodies (anti-sp100 and anti gp-120) with the histological classification (i.e., early versus advanced disease). This evidence concerns the gene ITIH4 and primary biliary cholangitis.